Short Summary
The PTAB institution decision found a reasonable likelihood of unpatentability for several claims in the dermatological treatment patent, primarily based on anticipation by reference Mehta. The Board rejected arguments for discretionary denial and proceeded with the IPR.
Detailed Summary
In this Institution Decision (IPR2024-00463), the PTAB ruled that the petitioner, Jeisys Medical Inc., met the threshold for institution because it demonstrated a reasonable likelihood of proving anticipation by reference Mehta against claims 2, 8, and 13. The Board specifically rejected Serendia's arguments for discretionary denial under General Plastic/Valve and 35 U.S.C. § 325(d), finding that the primary prior art (Mehta) was materially different from the prosecution reference but still disclosed relevant features. Despite disputes over claim construction, the Board found the anticipation likelihood sufficient to proceed with the IPR on 12 claims.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Ilooda Co., Ltd. et al. vs Serendia, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Google LLCvsDH International Ltd.
The PTAB denied Google LLC's request for Director Review of the institution decision in IPR2024-01322, leaving the institution of patent 9,022,294 B2 in place.
Zhuhai CosMX Battery Co., Ltd.vsNingde Amperex Technology Ltd.
The PTAB denied Zhuhai CosMX Battery’s request for Director Review of the institution denial in IPR2025‑00385 concerning battery patent 10,964,927. The denial leaves the original decision that the IPR was not instituted intact.
Be Smarter, LLC et al.vsYondr, Inc.
Dr. Gregory D. Buckner, an expert for Be Smarter, submits a declaration asserting that the ’788 patent’s claims 1‑4 and 6‑8 are anticipated or obvious over earlier security‑case designs such as Samuel, Shin, and Simpson. He finds no secondary evidence of non‑obviousness and supports the petition for inter‑partes review.
Samsung Electronics Co., Ltd. et al.vsCerence Operating Company
Samsung has filed an IPR petition seeking cancellation of all 20 claims of Cerence’s ’671 patent, arguing they are obvious over existing text‑to‑speech technologies. The petition also argues that discretionary factors favor instituting the review.
Meta Platforms, Inc.vsSitNet, LLC
Meta Platforms successfully challenged SitNet’s ’682 patent covering situational networks. The PTAB found all 20 claims unpatentable as obvious over prior art references Burfeind and Crowley. The patent owner did not respond, leaving the petitioner’s arguments unopposed.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.